1. Abasi M, Rezaei R & Dehghani G (1393). "The Concept and Place of the Right to Health in Iran legal System". Journal of medical law, 30(2):138-146. (Persian) 2. Chorev, N & Shadlen, K (2015).»Intellectual Property, Access to Medicine, and Health«. New Research Horizon, 50(2):143-156. [ DOI:10.1007/s12116-015-9182-6] 3. Congressional Research Service (2020). COVID-19: International Trade and Access to Pharmaceutical Products. Available on: https://crsreports.congress.gov/ (Last visit: 2020) 4. Helfer, L (2003). »Human Rights and Intellectual Property: Conflict or Coexistence?«. Minnesota Intellectual Property Review, 5(1):47-61. [ DOI:10.2139/ssrn.459120] 5. Hoen, E (2002). »TRIPS, Pharmaceutical Patents and Access to Essential Medicines«. Chicago Journal for International Law, 3(1):39-67. 6. Joo-Young J & Paul H (2012) .»Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines«. J.L. Med. & Ethics, 40(22):220-233. [ DOI:10.1111/j.1748-720X.2012.00660.x] 7. Khedmatgozar, M (1391). Philosophy of Intellectual Property. 2nd ed. Tehran: Mizan Publishing. (Persian) 8. M. Ho, C (2007). »A New World Order for Addressing Patent Rights and Public Health«. Chicago-Kent Law Review, 82(3):1470-1515. 9. Management Science for Health (2012). Intellectual Property and Access to Medicines. Available on: https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies. (Last visit: 2020) 10. Mirhosseini, SH (1395). Patents Law. 2nd ed. Tehran: Mizan Publishing. (Persian) 11. Monfared, M (1394). "Conflict of Pharmaceutical Patents and Protection of Human Rights; Legal Interpretation of Article 27 of TRIPS Agreement". Journal of medical law, 6(0):151-187. (Persian) 12. Nazemi, N (1397). "The encounter between Access to Medicine and the right of pharmaceutical patents in the light of TRIPS Agreement". The Conference of global modern achievements in the field of education, Psychology, Law and sociocultural studies.(Persian) 13. Niavarani, S & Javid E (1395). "The right of Access to Essential Medicines in the Frame of TRIPS Agreement and the Challenge of Protection of the International Human Right to Health«. Journal of international Law, 54:29-58. (Persian) 14. Rimmer, M (2004). »The Race to Patent the Sars Virus: The Trips Agreement and Access to Essential Medicines«. Melbourne Journal of International Law, 5 (2):335-374. 15. WHO (2017). Advancing the Right to Health: the Vital Role of Law. Available on: https://www.who.int/gender-equity-rights/knowledge. (Last visit: 2020) 16. Wu, C (2012). »Transnational Pharmaceutical Corporations' Legal and Moral Human Rights Responsibilities in Relation to Access to Medicines«. Asian Journal of WTO and International Health Law and Policy, 7(1):77-142. 17. Sadeghi, M (1388).» Protection of pharmaceutival Patents and the Challenges of human rights«. Journal of Law, law and political sciences, 39 (3):193-215. (Persian) 18. Sheikhi, M (1385). "The Challenges of Intellectual Property Rights in the Health Field". Journal of social welfare, 5(20): 61-82. (Persian)
|